AAD and NPF Release Joint Guideline on New and Standard Therapies for Psoriasis

A new joint statement from the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) provides clinicians updated guidance on the use of systemic and non-biologic medications for the treatment of psoriasis.

The guideline was published in the Journal of the American Academy of Dermatology.

Source link

Related posts

‘Exceeding Expectations’: Conjoined Twins Happy, Healthy After Separation Surgery


Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p.


Can A Custom Skull Implant Create A More Square-Shaped Head?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy